DUS3L
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like
Also known as: DUS3, DUS3L_HUMAN, FLJ13896
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96G46
- Gene
- DUS3L
- Ensembl
- ENSG00000141994
- Chromosome
- 19
- Canonical length
- 650 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables mRNA dihydrouridine synthase activity and tRNA-dihydrouridine47 synthase activity. Involved in regulation of translation and tRNA dihydrouridine synthesis. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
650 residues, UniProt reviewed canonical sequence.
>Q96G46|DUS3L
1 MAEGTAEAPL ENGGGGDSGA GALERGVAPI KRQYLTTKEQ FHQFLEAKGQ EKTCRETEVG
61 DPAGNELAEP EAKRIRLEDG QTADGQTEEA AEPGEQLQTQ KRARGQNKGR PHVKPTNYDK
121 NRLCPSLIQE SAAKCFFGDR CRFLHDVGRY LETKPADLGP RCVLFETFGR CPYGVTCRFA
181 GAHLRPEGQN LVQEELAARG TQPPSIRNGL DKALQQQLRK REVRFERAEQ ALRRFSQGPT
241 PAAAVPEGTA AEGAPRQENC GAQQVPAGPG TSTPPSSPVR TCGPLTDEDV VRLRPCEKKR
301 LDIRGKLYLA PLTTCGNLPF RRICKRFGAD VTCGEMAVCT NLLQGQMSEW ALLKRHQCED
361 IFGVQLEGAF PDTMTKCAEL LSRTVEVDFV DINVGCPIDL VYKKGGGCAL MNRSTKFQQI
421 VRGMNQVLDV PLTVKIRTGV QERVNLAHRL LPELRDWGVA LVTLHGRSRE QRYTKLADWQ
481 YIEECVQAAS PMPLFGNGDI LSFEDANRAM QTGVTGIMIA RGALLKPWLF TEIKEQRHWD
541 ISSSERLDIL RDFTNYGLEH WGSDTQGVEK TRRFLLEWLS FLCRYVPVGL LERLPQRINE
601 RPPYYLGRDY LETLMASQKA ADWIRISEML LGPVPPSFAF LPKHKANAYKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUS3L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- testis: 39 nTPM
- liver: 25 nTPM
- skin: 25 nTPM
- pancreas: 24 nTPM
- esophagus: 21 nTPM
- spleen: 20 nTPM
Single-cell type
- late primary spermatocytes: 130 nCPM
- esophageal basal cells: 35 nCPM
- early spermatids: 33 nCPM
- migrating cytotrophoblasts: 32 nCPM
- syncytiotrophoblasts: 31 nCPM
- paneth cells: 31 nCPM
Immune cell
- plasmacytoid DC: 31 nTPM
- intermediate monocyte: 30 nTPM
- myeloid DC: 30 nTPM
- NK-cell: 28 nTPM
- non-classical monocyte: 26 nTPM
- MAIT T-cell: 25 nTPM
Brain region
- white matter: 16 nTPM
- medulla oblongata: 15 nTPM
- cerebral cortex: 14 nTPM
- thalamus: 13 nTPM
- midbrain: 12 nTPM
- pons: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.53
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- flavin adenine dinucleotide binding
- RNA binding
- tRNA dihydrouridine synthase activity
- zinc ion binding
- mRNA dihydrouridine synthase activity
- tRNA-dihydrouridine47 synthase activity
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DUS3L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUS3L as an antibody target. Whether an autoantibody or antibody against DUS3L could matter depends on whether native DUS3L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUS3L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUS3L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...